Immunotherapy: Cancer immunotherapy and the value of cure

doi:10.1038/nrclinonc.2018.27

Comment

. 2018 May;15(5):268-270.

doi: 10.1038/nrclinonc.2018.27. Epub 2018 Feb 20.

Immunotherapy: Cancer immunotherapy and the value of cure

Joseph C Del Paggio¹

Affiliations

PMID: 29459643
DOI: 10.1038/nrclinonc.2018.27

Comment

Immunotherapy: Cancer immunotherapy and the value of cure

Joseph C Del Paggio. Nat Rev Clin Oncol. 2018 May.

. 2018 May;15(5):268-270.

doi: 10.1038/nrclinonc.2018.27. Epub 2018 Feb 20.

Author

Joseph C Del Paggio¹

Affiliation

¹ Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Canada.

PMID: 29459643
DOI: 10.1038/nrclinonc.2018.27

No abstract available

PubMed Disclaimer

Comment on

Association of Immunotherapy With Durable Survival as Defined by Value Frameworks for Cancer Care.
Ben-Aharon O, Magnezi R, Leshno M, Goldstein DA. Ben-Aharon O, et al. JAMA Oncol. 2018 Mar 1;4(3):326-332. doi: 10.1001/jamaoncol.2017.4445. JAMA Oncol. 2018. PMID: 29285547 Free PMC article.

Cited by

Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockade.
Fang T, Cao X, Wang L, Chen M, Deng Y, Chen G. Fang T, et al. Bioact Mater. 2023 Nov 3;32:530-542. doi: 10.1016/j.bioactmat.2023.10.023. eCollection 2024 Feb. Bioact Mater. 2023. PMID: 38026439 Free PMC article.
Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia.
Zhang Y, Li Z, Huang Y, Zou B, Xu Y. Zhang Y, et al. Front Immunol. 2023 Oct 6;14:1258786. doi: 10.3389/fimmu.2023.1258786. eCollection 2023. Front Immunol. 2023. PMID: 37869003 Free PMC article. Review.
T Cell engineering for cancer immunotherapy by manipulating mechanosensitive force-bearing receptors.
Zhao L, Zhao G, Feng J, Zhang Z, Zhang J, Guo H, Lin M. Zhao L, et al. Front Bioeng Biotechnol. 2023 Jul 25;11:1220074. doi: 10.3389/fbioe.2023.1220074. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37560540 Free PMC article. Review.
Activity-based bioluminescence probes for in vivo sensing applications.
Yadav AK, Chan J. Yadav AK, et al. Curr Opin Chem Biol. 2023 Jun;74:102310. doi: 10.1016/j.cbpa.2023.102310. Epub 2023 Apr 27. Curr Opin Chem Biol. 2023. PMID: 37119771 Review.
Classification of triple-negative breast cancer based on pathway enrichment levels.
Liu Q, Wang X. Liu Q, et al. Med Oncol. 2023 Apr 24;40(6):157. doi: 10.1007/s12032-023-02021-w. Med Oncol. 2023. PMID: 37093316

See all "Cited by" articles

References

1. Ann Oncol. 2017 Oct 1;28(10 ):2340-2366 - PubMed
1. J Natl Cancer Inst. 2017 Dec 13;:null - PubMed
1. JAMA Oncol. 2018 Mar 1;4(3):326-332 - PubMed
1. Value Health. 2017 Feb;20(2):217-223 - PubMed
1. J Clin Oncol. 2016 Aug 20;34(24):2925-34 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- scite Smart Citations

[1] Ann Oncol. 2017 Oct 1;28(10 ):2340-2366 - PubMed

[2] Ann Oncol. 2017 Oct 1;28(10 ):2340-2366 - PubMed

[3] J Natl Cancer Inst. 2017 Dec 13;:null - PubMed

[4] J Natl Cancer Inst. 2017 Dec 13;:null - PubMed

[5] JAMA Oncol. 2018 Mar 1;4(3):326-332 - PubMed

[6] JAMA Oncol. 2018 Mar 1;4(3):326-332 - PubMed

[7] Value Health. 2017 Feb;20(2):217-223 - PubMed

[8] Value Health. 2017 Feb;20(2):217-223 - PubMed

[9] J Clin Oncol. 2016 Aug 20;34(24):2925-34 - PubMed

[10] J Clin Oncol. 2016 Aug 20;34(24):2925-34 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Immunotherapy: Cancer immunotherapy and the value of cure

Affiliation

Immunotherapy: Cancer immunotherapy and the value of cure

Author

Affiliation

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources